Expertise in
13
conditions

Hideaki Shiraishi

Tochigi, JP 
Expertise in
13
conditions
Tochigi, JP 

Overview

Hideaki Shiraishi practices practicing medicine in Tochigi, Japan.

Shiraishi is highly rated in 13 conditions, according to our data. Their clinical expertise encompasses Angelman Syndrome, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Epilepsy, and Seizures.

They are actively involved in clinical research, co-authoring 105 peer reviewed articles and participating in 3 clinical trials.

Locations

Tochigi, Japan
Other Locations
Mibu, 3210293, Japan
Sapporo, 0608638, Japan
Chiyoda, 1018643, Japan
Tokyo, 1018643, Japan
0608648, Japan
Chuo, 1040045, Japan
Chiba, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Efficacy and Safety Study of Vatiquinone for the Treatment of Mitochondrial Disease Subjects With Refractory Epilepsy
Efficacy and Safety Study of Vatiquinone for the Treatment of Mitochondrial Disease Subjects With Refractory Epilepsy
Enrollment Status: Terminated
Publish Date: March 31, 2026
Intervention Type: Other, Drug
Study Drug: Vatiquinone
Study Phase: Phase 2/Phase 3
A Phase 3, Multicenter, Open-label Extension Study of Buccally Administered MHOS/SHP615 in Pediatric Patients With Status Epilepticus (Convulsive) in Community Settings
A Phase 3, Multicenter, Open-label Extension Study of Buccally Administered MHOS/SHP615 in Pediatric Patients With Status Epilepticus (Convulsive) in Community Settings
Enrollment Status: Completed
Publish Date: September 14, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Multicenter, Open-label Study to Determine the Efficacy, Safety, and Pharmacokinetics of Buccally Administered MHOS/SHP615 in Pediatric Patients With Status Epilepticus (Convulsive) in the Hospital or Emergency Room
A Phase 3, Multicenter, Open-label Study to Determine the Efficacy, Safety, and Pharmacokinetics of Buccally Administered MHOS/SHP615 in Pediatric Patients With Status Epilepticus (Convulsive) in the Hospital or Emergency Room
Enrollment Status: Completed
Publish Date: July 31, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

105 Total Publications

Nemolizumab efficacy for severe sleep disturbance in pediatric atopic dermatitis with mild skin lesions.
Nemolizumab efficacy for severe sleep disturbance in pediatric atopic dermatitis with mild skin lesions.
Journal: JAAD case reports
Published: June 12, 2026

Frequently Asked Questions about Hideaki Shiraishi

Is Hideaki Shiraishi a top-rated expert for Angelman Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Hideaki Shiraishi is classified as an Distinguished expert for Angelman Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hideaki Shiraishi participate in research or clinical trials?

Yes. Hideaki Shiraishi has published 105 articles and abstracts on conditions like Angelman Syndrome. You can view a list of Hideaki Shiraishi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shiraishi's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 48 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile